{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:03:05Z","timestamp":1771401785798,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["GZC20233559"],"award-info":[{"award-number":["GZC20233559"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Fund for the Basic Medical Research for the youth of the Changhai Hospital","award":["20230024"],"award-info":[{"award-number":["20230024"]}]},{"name":"Special Program for Clinical Medicine Research","award":["2024LYC015"],"award-info":[{"award-number":["2024LYC015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06834-3","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T08:55:55Z","timestamp":1770108955000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Addition of rituximab to CEAC conditioning for autologous hematopoietic stem cell transplantation provides no survival benefit in diffuse large B-Cell lymphoma: A propensity score-matched cohort study"],"prefix":"10.1007","volume":"105","author":[{"given":"Chaoshuai","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanni","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyue","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruobing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guihua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"6834_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1056\/NEJMra2027612","volume":"384","author":"LH Sehn","year":"2021","unstructured":"Sehn LH, Salles G, Diffuse Large B-C, Lymphoma (2021) N Engl J Med 384:842\u2013858. https:\/\/doi.org\/10.1056\/NEJMra2027612","journal-title":"N Engl J Med"},{"key":"6834_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346:235\u2013242","journal-title":"N Engl J Med"},{"key":"6834_CR3","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B et al (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the groupe d\u2019etudes des lymphomes de l\u2019adulte. Blood 116:2040\u20132045. https:\/\/doi.org\/10.1182\/blood-2010-03-276246","journal-title":"Blood"},{"key":"6834_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1182\/blood-2007-08-108415","volume":"111","author":"E Vellenga","year":"2008","unstructured":"Vellenga E et al (2008) Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed\/progressive aggressive CD20\u2009+\u2009NHL: a prospective randomized HOVON trial. Blood 111:537\u2013543. https:\/\/doi.org\/10.1182\/blood-2007-08-108415","journal-title":"Blood"},{"key":"6834_CR5","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1182\/blood-2017-03-769620","volume":"130","author":"M Crump","year":"2017","unstructured":"Crump M et al (2017) Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood 130:1800\u20131808. https:\/\/doi.org\/10.1182\/blood-2017-03-769620","journal-title":"Blood"},{"key":"6834_CR6","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","volume":"28","author":"C Gisselbrecht","year":"2010","unstructured":"Gisselbrecht C et al (2010) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncology: Official J Am Soc Clin Oncol 28:4184\u20134190. https:\/\/doi.org\/10.1200\/JCO.2010.28.1618","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"6834_CR7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/sj.bmt.1700913","volume":"20","author":"MD Caballero","year":"1997","unstructured":"Caballero MD et al (1997) BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant 20:451\u2013458","journal-title":"Bone Marrow Transplant"},{"key":"6834_CR8","first-page":"25","volume":"52","author":"AV Dudhatra","year":"2017","unstructured":"Dudhatra AV et al (2017) Autologous Haematopoietic stem cell transplantation using BEAM +\/-rituximab for relapsed diffuse large B cell lymphoma in the rituximab era-ten-year follow-up of single transplant center in Singapore. Bone Marrow Transplant 52:25\u201326","journal-title":"Bone Marrow Transplant"},{"key":"6834_CR9","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1002\/cncr.32752","volume":"126","author":"D Jagadeesh","year":"2020","unstructured":"Jagadeesh D et al (2020) Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. Cancer 126:2279\u20132287. https:\/\/doi.org\/10.1002\/cncr.32752","journal-title":"Cancer"},{"key":"6834_CR10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41409-020-01120-w","volume":"55","author":"C Rodriguez-Arocho","year":"2020","unstructured":"Rodriguez-Arocho C et al (2020) Higher cost and no survival benefit with addition of rituximab to beam conditioning for autologous transplantation in patients with relapsed\/refractory DLBCL. Bone Marrow Transplant 55:414\u2013415. https:\/\/doi.org\/10.1038\/s41409-020-01120-w","journal-title":"Bone Marrow Transplant"},{"key":"6834_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/bjh.14731","volume":"178","author":"SA Srour","year":"2017","unstructured":"Srour SA et al (2017) A randomized phase II study of standard-dose versus high-dose rituximab with BEAM in autologous stem cell transplantation for relapsed aggressive B-cell non-hodgkin lymphomas: long term results. Br J Haematol 178:561\u2013570. https:\/\/doi.org\/10.1111\/bjh.14731","journal-title":"Br J Haematol"},{"key":"6834_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00277-023-05513-x","volume":"103","author":"T Wang","year":"2023","unstructured":"Wang T et al (2023) CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients. Ann Hematol 103:575\u2013582. https:\/\/doi.org\/10.1007\/s00277-023-05513-x","journal-title":"Ann Hematol"},{"key":"6834_CR13","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD et al (2014) Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncology: Official J Am Soc Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"6834_CR14","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.bbmt.2009.07.017","volume":"15","author":"TS Fenske","year":"2009","unstructured":"Fenske TS et al (2009) Impact of Pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biol Blood Marrow Transplant 15:1455\u20131464. https:\/\/doi.org\/10.1016\/j.bbmt.2009.07.017","journal-title":"Biol Blood Marrow Transplant"},{"key":"6834_CR15","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1007\/s00259-002-0820-7","volume":"29","author":"K Scheidhauer","year":"2002","unstructured":"Scheidhauer K et al (2002) Biodistribution and kinetics of (131)I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin\u2019s lymphoma. Eur J Nucl Med Mol Imaging 29:1276\u20131282. https:\/\/doi.org\/10.1007\/s00259-002-0820-7","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6834_CR16","doi-asserted-by":"publisher","first-page":"55.e1","DOI":"10.1016\/j.bbmt.2020.09.004","volume":"27","author":"S Bal","year":"2021","unstructured":"Bal S, Costa LJ, Sauter C, Litovich C, Hamadani M (2021) Outcomes of autologous hematopoietic cell transplantation in diffuse large B cell lymphoma refractory to firstline chemoimmunotherapy. Transplantation Cell Therapy 27:55.e1\u201355.e7","journal-title":"Transplantation Cell Therapy"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06834-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06834-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06834-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T07:03:37Z","timestamp":1771398217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06834-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["6834"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06834-3","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}